GEORGE R BLUMENSCHEIN to Feasibility Studies
This is a "connection" page, showing publications GEORGE R BLUMENSCHEIN has written about Feasibility Studies.
Connection Strength
0.038
-
Adding Erlotinib to Chemoradiation Improves Overall Survival but Not Progression-Free Survival in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):317-24.
Score: 0.021
-
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial. J Thorac Oncol. 2013 Apr; 8(4):436-42.
Score: 0.018